Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Japanese Journal of Radiology
Published in: Japanese Journal of Radiology 10/2015

01-10-2015 | Original Article

Correlating Parkinson’s disease motor symptoms with three-dimensional [18F]FP-CIT PET

Authors: Moonyoung Chung, Young Seok Park, Ji Seon Kim, Yun Joong Kim, Hyeo Il Ma, Su jin Jang, Ryoong Huh, Hyun Sook Kim, Won-Chan Kim

Published in: Japanese Journal of Radiology | Issue 10/2015

Login to get access

Abstract

Purpose

To investigate the correlation between the striatal three-dimensional location and the Unified Parkinson’s Disease Rating Scale (UPDRS) motor score in the context of idiopathic Parkinson’s disease (PD) through radiolabeled N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane positron emission tomography/computed tomography (FP-CIT PET/CT).

Materials and methods

In this cross-sectional study, we assessed the UPDRS motor score and performed FP-CIT PET/CT in patients with PD. Thirty-eight patients with idiopathic PD [average 70 years of age (range 49–86); male:female ratio 12:26] were enrolled. The correlation between FP-CIT PET/CT and the UPDRS III scores was investigated after the transformation of PET images by an alternative method using MATLAB.

Results

Left caudate nucleus uptake negatively correlated with UPDRS items 18, 20 (face), 22 (right arm and leg), 23, 24 (right side), 26 (right side), 27, 30, and 31, while right caudate nucleus uptake positively correlated with items 18, 22 (left arm), 26, and 29. Putamen uptake correlated with items 22 and 25. Left caudate nucleus uptake positively correlated with axial and akinetic-rigidity symptoms.

Conclusions

FP-CIT uptake in specific basal ganglia structures strongly correlated with the UPDRS III motor score. Among these, the left caudate nucleus exhibited the strongest relationship with axial and akinetic-rigidity PD symptoms.
Literature
1.
Djaldetti R, Treves TA, Ziv I, Melamed E, et al. Use of a single [(123)I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci. 2009;30(4):301–5.CrossRefPubMed
2.
Eggers C, Kahraman D, Fink GR, et al. Akinetic-rigid and tremor-dominant Parkinson’s disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord. 2011;26:416–23.CrossRefPubMed
3.
Jellinger KA. Post mortem studies in Parkinson’s disease—is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1–29.CrossRefPubMed
4.
Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson’s disease. J Neuropathol Exp Neurol. 1991;50:743–55.CrossRefPubMed
5.
Rajput AH, Voll A, Rajput ML, Robinson CA, et al. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009;73:206–12.CrossRefPubMed
6.
Zaidel A, Arkadir D, Israel Z, et al. Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol. 2009;22:387–93.CrossRefPubMed
7.
Helmich RC, Hallett M, Deuschl G, Toni I, et al. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135:3206–26.PubMedCentralCrossRefPubMed
8.
Hilker R, Schweitzer K, Coburger S, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol. 2005;62:378–82.CrossRefPubMed
9.
10.
Louis ED, Tang MX, Cote L, et al. Progression of parkinsonian signs in Parkinson disease. Arch Neurol. 1999;56:334–7.CrossRefPubMed
11.
Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: clinical and prognostic implications. Neurology. 1985;35:522–6.CrossRefPubMed
12.
Spiegel J, Hellwig D, Samnick S, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm. 2007;114:331–5.CrossRefPubMed
13.
Stoessl AJ. Radionuclide scanning to diagnose Parkinson disease: is it cost-effective? Nat Clin Pract Neurol. 2009;5:10–1.CrossRefPubMed
14.
15.
Hubbuch M, Farmakis G, Schaefer A, et al. FP-CIT SPECT does not predict the progression of motor symptoms in Parkinson’s disease. Eur Neurol. 2011;65:187–92.CrossRefPubMed
16.
Ottaviani S, Tinazzi M, Pasquin I, et al. Comparative analysis of visual and semi-quantitative assessment of striatal [123I] FP-CIT-SPET binding in Parkinson’s disease. Neurol Sci. 2006;27:397–401.CrossRefPubMed
17.
Kahraman D, Eggers C, Schicha H, et al. Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson’s disease. J Neurol. 2012;259:251–60.CrossRefPubMed
18.
O’Brien JT, Colloby S, Fenwick J, et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol. 2004;61:919–25.CrossRefPubMed
19.
Papathanasiou N, Rondogianni P, Chroni P, Datseris I, et al. Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies. Ann Nucl Med. 2012;26:234–40.CrossRefPubMed
20.
Vingerhoets FJ, Schulzer M, Calne DB, et al. Which clinical sign of Parkinson’s disease best reflects the nigrostriatal lesion? Ann Neurol. 1997;41:58–64.CrossRefPubMed
21.
Wang J, Zuo CT, Jiang YP, et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson’s disease in various Hoehn & Yahr stages. J Neurol. 2007;254:185–90.CrossRefPubMed
22.
Kazumata K, Dhawan V, Chaly T, et al. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.PubMed
23.
Benamer HT, Patterson J, Wyper DJ, et al. Correlation of Parkinson’s disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord. 2000;15:692–8.CrossRefPubMed
24.
Berti V, Pupi A, Ramat S, et al. Clinical correlation of the binding potential with 123I-FP-CIT in de novo idiopathic Parkinson’s disease patients. Eur J Nucl Med Mol Imaging. 2008;35:2220–6.CrossRefPubMed
25.
Ma Y, Dhawan V, Mentis M, et al. Parametric mapping of [18F]FPCIT binding in early stage Parkinson’s disease: a PET study. Synapse. 2002;45:125–33.CrossRefPubMed
Metadata
Title
Correlating Parkinson’s disease motor symptoms with three-dimensional [18F]FP-CIT PET
Authors
Moonyoung Chung
Young Seok Park
Ji Seon Kim
Yun Joong Kim
Hyeo Il Ma
Su jin Jang
Ryoong Huh
Hyun Sook Kim
Won-Chan Kim
Publication date
01-10-2015
Publisher
Springer Japan
Published in
Japanese Journal of Radiology / Issue 10/2015
Print ISSN: 1867-1071
Electronic ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-015-0427-0

Other articles of this Issue 10/2015

Japanese Journal of Radiology 10/2015 Go to the issue

Case Report

Phlebosclerotic colitis: case report and literature review focused on the radiologic findings in relation to the intake period of toxic material

Case Report

Prenatal diagnosis of total arhinia by MRI

Original Article

CT measurement of splenic volume changes as a result of hypovolemic shock

Original Article

Persistence of lymphocytopenia with CT abnormalities among patients with critical H7N9 swine-origin influenza A virus infection

Special Report

Getting published in Radiology: A Deputy Editor’s perspective

Original Article

Correlation between the ABC classification and radiological findings for assessing gastric cancer risk